Contact
searchSearch
HMP Global

January 2014 - FRMC

Evaluation of Errors When Using e-Prescribing
01/21/2014
San Antonio—While electronic prescribing (e-prescribing) has been widely recommended for its ability to reduce medication errors, especially transcription errors; however, according to recent study literature, the rates of e-prescribing...
San Antonio—While electronic prescribing (e-prescribing) has been widely recommended for its ability to reduce medication errors, especially transcription errors; however, according to recent study literature, the rates of e-prescribing...
San Antonio—While electronic...
01/21/2014
First Report Managed Care
Alternative Distribution Strategies: “Buy and Bill” and “White Bagging”
01/21/2014
When handling specialty drugs, physicians typically purchase the medications directly from distributors, administer them to patients, and then bill payers.
When handling specialty drugs, physicians typically purchase the medications directly from distributors, administer them to patients, and then bill payers.
When handling specialty drugs,...
01/21/2014
First Report Managed Care
Stenting Added to Medical Therapy for Atherosclerotic Renal Artery Stenosis
01/21/2014
Dallas—Stenting added to medical therapy did not reduce the rate of major cardiovascular and renal events compared with medical therapy alone in patients with atherosclerotic renal artery stenosis and hypertension or chronic kidney disease,...
Dallas—Stenting added to medical therapy did not reduce the rate of major cardiovascular and renal events compared with medical therapy alone in patients with atherosclerotic renal artery stenosis and hypertension or chronic kidney disease,...
Dallas—Stenting added to medical...
01/21/2014
First Report Managed Care
Edoxaban Versus Warfarin for Patients with AF
01/21/2014
Dallas—A randomized, double-blind trial that included patients with atrial fibrillation (AF) found that 2, once-daily doses of edoxaban were noninferior to warfarin in preventing strokes or systemic embolic events. Patients who received...
Dallas—A randomized, double-blind trial that included patients with atrial fibrillation (AF) found that 2, once-daily doses of edoxaban were noninferior to warfarin in preventing strokes or systemic embolic events. Patients who received...
Dallas—A randomized,...
01/21/2014
First Report Managed Care
Combination of Treatment for PAD Yielded Better Results
01/21/2014
Dallas—Patients with peripheral arterial disease (PAD) and intermittent claudication who underwent endovascular revascularization and supervised exercise therapy had a significant improvement in walking distance and quality of life compared...
Dallas—Patients with peripheral arterial disease (PAD) and intermittent claudication who underwent endovascular revascularization and supervised exercise therapy had a significant improvement in walking distance and quality of life compared...
Dallas—Patients with peripheral...
01/21/2014
First Report Managed Care
High Frequency Source Ablation Similar to Standard Treatment for AF
01/21/2014
Dallas—A prospective, multi-center, single-blind, randomized trial found that patients with paroxysmal, symptomatic, drug-refractory atrial fibrillation (AF) had no significant difference in freedom from AF or atrial tachyarrhythmias after 1...
Dallas—A prospective, multi-center, single-blind, randomized trial found that patients with paroxysmal, symptomatic, drug-refractory atrial fibrillation (AF) had no significant difference in freedom from AF or atrial tachyarrhythmias after 1...
Dallas—A prospective,...
01/21/2014
First Report Managed Care
CATIS Trial on Blood Pressure Reduction
01/21/2014
Dallas—Previous clinical trials have found that lowering blood pressure (BP) reduces the risk of stroke in hypertensive and normotensive patients with a history of stroke or transient ischemic attack. However, the effect of antihypertensive...
Dallas—Previous clinical trials have found that lowering blood pressure (BP) reduces the risk of stroke in hypertensive and normotensive patients with a history of stroke or transient ischemic attack. However, the effect of antihypertensive...
Dallas—Previous clinical trials...
01/21/2014
First Report Managed Care
Ibrutinib to Treat CLL/SLL
01/21/2014
New Orleans—After at least a year of treatment with ibrutinib, more than 80% of patients with treatment-naïve or relapsed/refractory chronic lymphocytic leukemia/small lymphocytic leukemia (CLL/SLL) had a partial or complete response,...
New Orleans—After at least a year of treatment with ibrutinib, more than 80% of patients with treatment-naïve or relapsed/refractory chronic lymphocytic leukemia/small lymphocytic leukemia (CLL/SLL) had a partial or complete response,...
New Orleans—After at least a...
01/21/2014
First Report Managed Care

Department

Conference Insider
Low Adherence Rates for Patients with Severe Hemophilia
01/21/2014
San Antonio—Prophylaxis with factor VII or IX has been shown to reduce bleeding episodes for patients with hemophilia A and B; however, a recent study finds that most individuals with severe hemophilia are not adherent to a routine...
San Antonio—Prophylaxis with factor VII or IX has been shown to reduce bleeding episodes for patients with hemophilia A and B; however, a recent study finds that most individuals with severe hemophilia are not adherent to a routine...
San Antonio—Prophylaxis with...
01/21/2014
First Report Managed Care
Conference Insider
Long-Term Results of Evolocumab to Treat Hypercholesterolemia
01/21/2014
Dallas—After a year of treatment, patients with hypercholesterolemia who received evolocumab plus the standard of care had a mean reduction of 50% in low-density lipoprotein (LDL) cholesterol compared with a group that took optimal standard...
Dallas—After a year of treatment, patients with hypercholesterolemia who received evolocumab plus the standard of care had a mean reduction of 50% in low-density lipoprotein (LDL) cholesterol compared with a group that took optimal standard...
Dallas—After a year of...
01/21/2014
First Report Managed Care
FRMC Volume 21, Issue 4

Current Issue

October/November/December Volume 21, Issue 4, First Report Managed Care
Current Issue
Issue Archive

What's Trending?

News
Regeneron/Sanofi Heart Drug Succeeds in Major Trial; Will Insurers Pay?
03/12/2018
Praluent significantly reduced major adverse heart events in a recent study, but it remains to be seen whether the new data will prompt insurers to pay for increased use of the medicine.
Praluent significantly reduced major adverse heart events in a recent study, but it remains to be seen whether the new data will prompt insurers to pay for increased use of the medicine.
Praluent significantly reduced...
03/12/2018
First Report Managed Care
News
Report: Employers to see 2011 medical costs jump
06/14/2010
06/14/2010
First Report Managed Care
Conference Insider
Integrating Managed Care and Medicaid
06/18/2015
In 2013, state and local Medicaid spending increased 5.9% and federal Medicaid spending increased 6.2%, with a total increase of 6.1% in Medicaid expenditures.
In 2013, state and local Medicaid spending increased 5.9% and federal Medicaid spending increased 6.2%, with a total increase of 6.1% in Medicaid expenditures.
In 2013, state and local...
06/18/2015
First Report Managed Care
News
HHS grants 106 new healthcare waivers
08/23/2011
08/23/2011
First Report Managed Care
News
Quality Improvement Program for Skilled Nursing Facilities
12/15/2014
Generally, elderly hospital readmissions are associated with high cost and poor outcomes.
Generally, elderly hospital readmissions are associated with high cost and poor outcomes.
Generally, elderly hospital...
12/15/2014
First Report Managed Care

Video Insights

Formoso Headshot
Videos
Minimally Invasive Solutions for Lumbar Disc Herniation
01/07/2025
In this interview, Ferdinand Formoso, DO, discusses the role of condoliase as a minimally invasive treatment for lumbar disc herniation, its safety profile, potential areas for further research, and its ability to address unmet needs in spine...
In this interview, Ferdinand Formoso, DO, discusses the role of condoliase as a minimally invasive treatment for lumbar disc herniation, its safety profile, potential areas for further research, and its ability to address unmet needs in spine...
In this interview, Ferdinand...
01/07/2025
First Report Managed Care
Kolodziej Headshot
Videos
Navigating Biosimilar Adoption: Lessons from Global Markets and Clinical Practices
12/20/2024
In this interview, Michael Kolodziej, MD, discusses strategies for enhancing biosimilar adoption in the US, emphasizing lessons from global markets, the importance of payer flexibility, and the need for collaboration to reduce costs and...
In this interview, Michael Kolodziej, MD, discusses strategies for enhancing biosimilar adoption in the US, emphasizing lessons from global markets, the importance of payer flexibility, and the need for collaboration to reduce costs and...
In this interview, Michael...
12/20/2024
First Report Managed Care
Mike Kolodziej, MD
Videos
Exploring Biosimilar Adoption and Policy Impacts in Oncology
12/18/2024
In this interview, Michael Kolodziej, MD, discusses the role of biosimilars in value-based care models, their relationship with targeted therapies, and the impact of policy changes and market trends on biosimilar adoption and cost...
In this interview, Michael Kolodziej, MD, discusses the role of biosimilars in value-based care models, their relationship with targeted therapies, and the impact of policy changes and market trends on biosimilar adoption and cost...
In this interview, Michael...
12/18/2024
First Report Managed Care
Hennessy Headshot
Videos
Navigating Biosimilar Integration: Cost Savings, Coverage, and Future Strategies for Payers
12/10/2024
John Hennessy, MBA, discusses the complexities of biosimilar adoption, highlighting potential cost savings, payer strategies, challenges in provider and patient acceptance, regulatory impacts, and the critical need for sustainable market...
John Hennessy, MBA, discusses the complexities of biosimilar adoption, highlighting potential cost savings, payer strategies, challenges in provider and patient acceptance, regulatory impacts, and the critical need for sustainable market...
John Hennessy, MBA, discusses...
12/10/2024
First Report Managed Care
Videos
Bridging the Gaps in Prior Authorization: Challenges, Solutions, and Collaboration for Better Patient Care
11/13/2024
David Sand, MD, MBA, chief medical officer at ZeOmega, discusses the challenges of prior authorization, emphasizing the need for transparency, evidence-based standards, collaboration between payers and providers, and the potential for...
David Sand, MD, MBA, chief medical officer at ZeOmega, discusses the challenges of prior authorization, emphasizing the need for transparency, evidence-based standards, collaboration between payers and providers, and the potential for...
David Sand, MD, MBA, chief...
11/13/2024
First Report Managed Care
Richard Lipton, MD
Videos
The Evolving Role of CGRP-targeting Therapies in Migraine Prevention
10/31/2024
Richard Lipton, MD, provides insights on the American Headache Society’s position statement update on calcitonin gene-related peptide (CGRP)-targeting therapies as a first-line option for the prevention of migraine.
Richard Lipton, MD, provides insights on the American Headache Society’s position statement update on calcitonin gene-related peptide (CGRP)-targeting therapies as a first-line option for the prevention of migraine.
Richard Lipton, MD, provides...
10/31/2024
First Report Managed Care
Alexander Spira, MD, PhD
Videos
Unmet Needs in the Treatment and Management of Non–Small Cell Lung Cancer
09/26/2024
Alexander I. Spira, MD, PhD, discusses significant unmet needs in the treatment and management of non–small cell lung cancer (NSCLC).
Alexander I. Spira, MD, PhD, discusses significant unmet needs in the treatment and management of non–small cell lung cancer (NSCLC).
Alexander I. Spira, MD, PhD,...
09/26/2024
First Report Managed Care
Videos
Treatment Options for NSCLC: A Discussion on Coverage, Clinical Outcomes, and Payer Perspectives
09/25/2024
Learn about research developments in 1L therapy for NSCLC patients with EGFR mutations and how outcomes may impact coverage and reimbursement decisions for insurers.
Learn about research developments in 1L therapy for NSCLC patients with EGFR mutations and how outcomes may impact coverage and reimbursement decisions for insurers.
Learn about research...
09/25/2024
First Report Managed Care
Title Card
Videos
Addressing the Root Cause of a Common Ocular Condition: A Virtual Roundtable
09/04/2024
View a roundtable discussion on Demodex blepharitis, a prevalent ocular condition that often goes undiagnosed in patients.
View a roundtable discussion on Demodex blepharitis, a prevalent ocular condition that often goes undiagnosed in patients.
View a roundtable discussion on...
09/04/2024
First Report Managed Care
Jordan Bazinsky
Videos
Addressing Health Disparities and Promoting Equity: The Role of Advanced Imaging Solutions
08/15/2024
Guest expert Jordan Bazinsky discusses the challenges facing the medical imaging industry, the potential of AI and emerging technologies, the role of advanced imaging solutions in promoting health equity, and the key trends and challenges...
Guest expert Jordan Bazinsky discusses the challenges facing the medical imaging industry, the potential of AI and emerging technologies, the role of advanced imaging solutions in promoting health equity, and the key trends and challenges...
Guest expert Jordan Bazinsky...
08/15/2024
First Report Managed Care

Subscribe to our eNewsletters!

First Report Managed Care Newsletter

January 2014 Volume 11 Issue 1

View Issue Archive
Editorial Correspondence

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use